Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis

Abstract Background Liver fibrosis is a transitional stage from hepatitis to cirrhosis, and hepatitis B virus (HBV) is the most common cause of liver disease. Transcriptome sequencing technology and bioinformatics analysis are increasingly being used to screen diagnostic targets for liver fibrosis....

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Wang, Shuo Qin, Meng Yang, Xiaoling Wang
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:iLabmed
Subjects:
Online Access:https://doi.org/10.1002/ila2.30
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238967693606912
author Ying Wang
Shuo Qin
Meng Yang
Xiaoling Wang
author_facet Ying Wang
Shuo Qin
Meng Yang
Xiaoling Wang
author_sort Ying Wang
collection DOAJ
description Abstract Background Liver fibrosis is a transitional stage from hepatitis to cirrhosis, and hepatitis B virus (HBV) is the most common cause of liver disease. Transcriptome sequencing technology and bioinformatics analysis are increasingly being used to screen diagnostic targets for liver fibrosis. Methods The GSE171294 dataset of HBV‐induced liver fibrosis tissue and normal tissue was obtained from the Gene Expression Omnibus (GEO) public database and used to screen for differentially expressed mRNAs using R software. mRNAs with |log fold change| >1 and p < 0.05 were considered to be differentially expressed. A heat map was drawn to visualize the expression patterns of the differentially expressed mRNAs. To screen for candidate target mRNAs, the differentially expressed mRNAs were annotated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis. Finally, a protein–protein interaction (PPI) network was constructed to analyze the relationships between the differentially expressed mRNAs. Results A total of 243 differentially expressed mRNAs were identified (p < 0.05); 129 were up‐regulated and 114 were down‐regulated. The up‐regulated and down‐regulated mRNAs were significantly enriched in 16 and 8 KEGG pathways, respectively. The enriched KEGG pathways included Salmonella infection, Protein processing in the endoplasmic reticulum, IL‐17 signaling pathway, and Aldosterone synthesis and secretion. The enriched GO terms were related mainly to cell proliferation, apoptosis, endoplasmic reticulum complex assembly, and myosin synthesis. The PPI network contained 161 nodes and 120 pairs of interactions. The top 10 key nodes were CAV1, CD4, NR3C1, PDIA3, EZR, IRF4, SOX9, HSP90AB1, CD40, and SEC13. Conclusions Bioinformatics analysis of the transcriptome sequencing data in the GSE171294 dataset identified CD4, NR3C1, and EZR and other genes at key nodes as new targets for the treatment of liver fibrosis caused by HBV. These results provide new insights for HBV‐induced liver fibrosis research and clinical treatment.
format Article
id doaj-art-a097a2051ea24be8a6a7fd3e38e077c1
institution Kabale University
issn 2834-443X
2834-4448
language English
publishDate 2024-03-01
publisher Wiley
record_format Article
series iLabmed
spelling doaj-art-a097a2051ea24be8a6a7fd3e38e077c12025-08-20T04:01:16ZengWileyiLabmed2834-443X2834-44482024-03-0121273710.1002/ila2.30Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosisYing Wang0Shuo Qin1Meng Yang2Xiaoling Wang3Department of Clinical Laboratory Shanxi Hospital of Traditional Chinese Medicine Taiyuan Shanxi Province ChinaAcademy of Medical Sciences Shanxi Medical University Taiyuan Shanxi Province ChinaDepartment of Clinical Laboratory Shanxi Hospital of Traditional Chinese Medicine Taiyuan Shanxi Province ChinaDepartment of Clinical Laboratory Shanxi Hospital of Traditional Chinese Medicine Taiyuan Shanxi Province ChinaAbstract Background Liver fibrosis is a transitional stage from hepatitis to cirrhosis, and hepatitis B virus (HBV) is the most common cause of liver disease. Transcriptome sequencing technology and bioinformatics analysis are increasingly being used to screen diagnostic targets for liver fibrosis. Methods The GSE171294 dataset of HBV‐induced liver fibrosis tissue and normal tissue was obtained from the Gene Expression Omnibus (GEO) public database and used to screen for differentially expressed mRNAs using R software. mRNAs with |log fold change| >1 and p < 0.05 were considered to be differentially expressed. A heat map was drawn to visualize the expression patterns of the differentially expressed mRNAs. To screen for candidate target mRNAs, the differentially expressed mRNAs were annotated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis. Finally, a protein–protein interaction (PPI) network was constructed to analyze the relationships between the differentially expressed mRNAs. Results A total of 243 differentially expressed mRNAs were identified (p < 0.05); 129 were up‐regulated and 114 were down‐regulated. The up‐regulated and down‐regulated mRNAs were significantly enriched in 16 and 8 KEGG pathways, respectively. The enriched KEGG pathways included Salmonella infection, Protein processing in the endoplasmic reticulum, IL‐17 signaling pathway, and Aldosterone synthesis and secretion. The enriched GO terms were related mainly to cell proliferation, apoptosis, endoplasmic reticulum complex assembly, and myosin synthesis. The PPI network contained 161 nodes and 120 pairs of interactions. The top 10 key nodes were CAV1, CD4, NR3C1, PDIA3, EZR, IRF4, SOX9, HSP90AB1, CD40, and SEC13. Conclusions Bioinformatics analysis of the transcriptome sequencing data in the GSE171294 dataset identified CD4, NR3C1, and EZR and other genes at key nodes as new targets for the treatment of liver fibrosis caused by HBV. These results provide new insights for HBV‐induced liver fibrosis research and clinical treatment.https://doi.org/10.1002/ila2.30expression profilesHBVliver fibrosistranscriptome sequencing
spellingShingle Ying Wang
Shuo Qin
Meng Yang
Xiaoling Wang
Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
iLabmed
expression profiles
HBV
liver fibrosis
transcriptome sequencing
title Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
title_full Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
title_fullStr Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
title_full_unstemmed Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
title_short Identification of new diagnostic targets for hepatitis B virus‐induced liver fibrosis
title_sort identification of new diagnostic targets for hepatitis b virus induced liver fibrosis
topic expression profiles
HBV
liver fibrosis
transcriptome sequencing
url https://doi.org/10.1002/ila2.30
work_keys_str_mv AT yingwang identificationofnewdiagnostictargetsforhepatitisbvirusinducedliverfibrosis
AT shuoqin identificationofnewdiagnostictargetsforhepatitisbvirusinducedliverfibrosis
AT mengyang identificationofnewdiagnostictargetsforhepatitisbvirusinducedliverfibrosis
AT xiaolingwang identificationofnewdiagnostictargetsforhepatitisbvirusinducedliverfibrosis